Search filters

List of works by Qin Ning

A large real-world cohort study examining the effects of long-term entecavir on hepatocellular carcinoma and HBsAg seroclearance

scientific article published on 09 December 2019

Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China

scientific article published on 01 September 2020

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

scientific article published on 26 March 2020

Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial

scientific article published on 08 August 2020

Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region

scientific article published on 24 October 2019

Impact of Metabolic Risk Factors on the Severity and Outcome of Patients with Alcohol Associated Acute-on-Chronic Liver Failure

scientific article published on 24 September 2020

Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients

scientific article published on 29 May 2020

Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients

scientific article published on 25 June 2020

Roadmap to functional cure of chronic hepatitis B: An expert consensus

scientific article published on 19 June 2019

STING couples with PI3K to regulate actin reorganization during BCR activation

scientific article published on 22 April 2020

Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study

scientific article published on 06 June 2019

Sofosbuvir plus ribavirin with or without peginterferon for the treatment of HCV: Results from a Phase 3b study in China.

scientific article

Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity

scientific article published on 13 August 2019